-
1
-
-
0027771190
-
The Nordic Diltiazem Study: An intervention study in hypertension comparing calcium antagonist based treatment with conventional therapy
-
NORDIL Study Group. The Nordic Diltiazem Study: an intervention study in hypertension comparing calcium antagonist based treatment with conventional therapy. Blood Press 1993; 2: 312-21.
-
(1993)
Blood Press
, vol.2
, pp. 312-321
-
-
-
2
-
-
0024424101
-
The 1989 guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting
-
World Health Organization/International Society of Hypertension Fifth Mild Hypertension Conference. The 1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1989; 7: 689-93.
-
(1989)
J Hypertens
, vol.7
, pp. 689-693
-
-
-
3
-
-
0027461577
-
Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo
-
Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993; 328: 914-21.
-
(1993)
N Engl J Med
, vol.328
, pp. 914-921
-
-
Materson, B.J.1
Reda, D.J.2
Cushman, W.C.3
-
4
-
-
0024221113
-
Left ventricular hypertrophy: Epidemiological insights from the Framingham Heart Study
-
Levy D. Left ventricular hypertrophy: epidemiological insights from the Framingham Heart Study. Drugs 1988; 35 (suppl 5): 1-5.
-
(1988)
Drugs
, vol.35
, Issue.5 SUPPL.
, pp. 1-5
-
-
Levy, D.1
-
5
-
-
0025280867
-
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
-
Levy D, Garrison RJ, Sagae DD Kännel W B, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-66.
-
(1990)
N Engl J Med
, vol.322
, pp. 1561-1566
-
-
Levy, D.1
Garrison, R.J.2
Sagae, D.D.3
Kännel, W.B.4
Castelli, W.P.5
-
6
-
-
0026517517
-
Reversal of left ventricular hypertrophy in hypertensive patients: A metaanalysis of 109 treatment studies
-
Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110.
-
(1992)
Am J Hypertens
, vol.5
, pp. 95-110
-
-
Dahlöf, B.1
Pennert, K.2
Hansson, L.3
-
7
-
-
0029962323
-
Reversal of left ventricular hypertrophy in essential hypertension: A meta-analysis of randomized double-blind studies
-
Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA 1996; 275: 1507-13.
-
(1996)
JAMA
, vol.275
, pp. 1507-1513
-
-
Schmieder, R.E.1
Martus, P.2
Klingbeil, A.3
-
8
-
-
0000140996
-
Reversibility of left ventricular hypertrophy and malfunction by antihypertensive treatment
-
Hansson L, Birkenhäger WH, eds. Amsterdam: Elsevier Science BV
-
Jennings GL, Wong J. Reversibility of left ventricular hypertrophy and malfunction by antihypertensive treatment. In: Hansson L, Birkenhäger WH, eds. Handbook of hypertension, Vol 18: assessment of hypertensive organ damage. Amsterdam: Elsevier Science BV, 1997: 184-223.
-
(1997)
Handbook of Hypertension, Vol 18: Assessment of Hypertensive Organ Damage
, vol.18
, pp. 184-223
-
-
Jennings, G.L.1
Wong, J.2
-
9
-
-
0031908811
-
Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)
-
Schmieder RE, Schlaich MP, Klingbeil AU, Martus P. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996). Nephrol Dial Transplant 1998; 13: 564-69.
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 564-569
-
-
Schmieder, R.E.1
Schlaich, M.P.2
Klingbeil, A.U.3
Martus, P.4
-
10
-
-
0025347391
-
Blood pressure, stroke, and coronary heart disease, part 2: Short-term reductions in blood pressure-over-view of randomised drug trials in their epidemiological context
-
Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease, part 2: short-term reductions in blood pressure-over-view of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38.
-
(1990)
Lancet
, vol.335
, pp. 827-838
-
-
Collins, R.1
Peto, R.2
MacMahon, S.3
-
11
-
-
0029830418
-
Shanghai trial of nifedipine in the elderly (STONE)
-
Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14: 1237-45.
-
(1996)
J Hypertens
, vol.14
, pp. 1237-1245
-
-
Gong, L.1
Zhang, W.2
Zhu, Y.3
-
12
-
-
0343487983
-
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
-
Staessen JA, Fagard R, Thijs L, et al, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-64.
-
(1997)
Lancet
, vol.350
, pp. 757-764
-
-
Staessen, J.A.1
Fagard, R.2
Thijs, L.3
-
13
-
-
0031769003
-
Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension
-
Liu L, Wang JG, Gong L, Liu G, Staessen JA, for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertens 1998; 16: 1823-29.
-
(1998)
J Hypertens
, vol.16
, pp. 1823-1829
-
-
Liu, L.1
Wang, J.G.2
Gong, L.3
Liu, G.4
Staessen, J.A.5
-
14
-
-
0033589756
-
Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension2 study
-
Hansson L, Lindholm LH, Ekbom T, et al, for the STOPHypertension-2 study group. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension2 study. Lancet 1999; 354: 1751-56.
-
(1999)
Lancet
, vol.354
, pp. 1751-1756
-
-
Hansson, L.1
Lindholm, L.H.2
Ekbom, T.3
-
15
-
-
0026911107
-
Prospective Randomized Open Blinded Endpoint (PROBE) study: A novel design for intervention trials
-
Hansson L, Hedner T, Dahlöf B. Prospective Randomized Open Blinded Endpoint (PROBE) study: a novel design for intervention trials. Blood Press 1992; 1: 113-19.
-
(1992)
Blood Press
, vol.1
, pp. 113-119
-
-
Hansson, L.1
Hedner, T.2
Dahlöf, B.3
-
16
-
-
0033494164
-
Progress report on the Nordic Diltiazem study (NORDIL): An outcome study in hypertensive patients
-
Hedner T, for the NORDIL Group. Progress report on the Nordic Diltiazem study (NORDIL): an outcome study in hypertensive patients. Blood Press 1999; 8: 296-99.
-
(1999)
Blood Press
, vol.8
, pp. 296-299
-
-
Hedner, T.1
-
17
-
-
0025287952
-
Effect of long-term diltiazem treatment on central haemodynamics and exercise endurance in essential hypertension
-
Lund-Johansen P, Omvik P. Effect of long-term diltiazem treatment on central haemodynamics and exercise endurance in essential hypertension. Eur Heart J 1990; 11: 543-51.
-
(1990)
Eur Heart J
, vol.11
, pp. 543-551
-
-
Lund-Johansen, P.1
Omvik, P.2
-
18
-
-
0030807893
-
Effect of calcium antagonists on plama norepinephrine levels, heart rate and blood pressure
-
Grossman E, Messerli FH. Effect of calcium antagonists on plama norepinephrine levels, heart rate and blood pressure. Am J Cardiol 1997;80:1453-58.
-
(1997)
Am J Cardiol
, vol.80
, pp. 1453-1458
-
-
Grossman, E.1
Messerli, F.H.2
-
19
-
-
0034685403
-
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2000; 283: 1967-75.
-
(2000)
JAMA
, vol.283
, pp. 1967-1975
-
-
-
20
-
-
0034635831
-
Implications of discontinuation of doxazosin arm of ALLHAT
-
Messerli FH. Implications of discontinuation of doxazosin arm of ALLHAT. Lancet 2000; 355: 863-64.
-
(2000)
Lancet
, vol.355
, pp. 863-864
-
-
Messerli, F.H.1
-
21
-
-
0033986682
-
Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients
-
Staessen JA, Birkenhäger WH, Fagard RH. Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients. Eur Heart J 2000; 21: 2-7.
-
(2000)
Eur Heart J
, vol.21
, pp. 2-7
-
-
Staessen, J.A.1
Birkenhäger, W.H.2
Fagard, R.H.3
-
22
-
-
0033034404
-
Effect of angiotensinconverting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
-
Hansson L, Lindholm LH, Niskanen L, et al, for the Captopril Prevention Project (CAPPP) Study Group.Effect of angiotensinconverting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999;353: 611-16.
-
(1999)
Lancet
, vol.353
, pp. 611-616
-
-
Hansson, L.1
Lindholm, L.H.2
Niskanen, L.3
-
23
-
-
0032511601
-
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
-
UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317: 713-20.
-
(1998)
BMJ
, vol.317
, pp. 713-720
-
-
|